Elhendy A, Cornel J H, Roelandt J R, van Domburg R T, Geleijnse M I, Nierop P R, Bax J J, Sciarra A, Ibrahim M M, el-Refaee M, el-Said G M, Fioretti P M
Thoraxcenter, University Hospital Rotterdam-Dijkzigt, Erasmus University, Rotterdam, The Netherlands.
Heart. 1997 Feb;77(2):115-21. doi: 10.1136/hrt.77.2.115.
To assess the relation between ST segment elevation during the dobutamine stress test and late improvement of function after acute Q wave myocardial infarction.
70 patients were studied a mean (SD) 8 (3) days after acute myocardial infarction with high dose dobutamine-atropine stress echocardiography and a follow up echocardiogram at 85 (10) days. A score model based on 16 segments and four grades was used to assess left ventricular function. Functional improvement was defined as a reduction of wall motion score > or = 1 in > or = 1 segments at follow up.
Myocardial revascularisation was performed in 23 patients (33%) before follow up studies.
ST segment elevation occurred in 40 patients (57%). Late functional improvement occurred in 35 patients (50%). Functional improvement was more common in patients with ST segment elevation (68% v 30%, P < 0.005) and they had a higher mean (SD) number of improved segments at follow up (1.9 (2.2) v 0.5 (1.1), P < 0.005). The wall motion score index decreased between baseline and follow up in patients with ST segment elevation (1.54 (0.50) v 1.48 (0.43), P < 0.05) but not in patients without ST segment elevation (1.39 (0.60) v 1.45 (0.47)). The accuracy of ST segment elevation for the prediction of functional improvement was similar to that of low dose dobutamine echocardiography in patients with anterior infarction (80% v 83%) and in patients who underwent revascularisation (78% v 83% respectively).
In patients with a recent Q wave myocardial infarction, dobutamine-induced ST segment elevation is a valuable marker of myocardial viability particularly when the test is performed without or with suboptimal echocardiographic imaging.
评估多巴酚丁胺负荷试验期间ST段抬高与急性Q波心肌梗死后晚期功能改善之间的关系。
对70例急性心肌梗死后平均(标准差)8(3)天的患者进行了大剂量多巴酚丁胺-阿托品负荷超声心动图检查,并在85(10)天进行了随访超声心动图检查。使用基于16节段和4个等级的评分模型评估左心室功能。功能改善定义为随访时≥1个节段的室壁运动评分降低≥1分。
23例患者(33%)在随访研究前进行了心肌血运重建。
40例患者(57%)出现ST段抬高。35例患者(50%)出现晚期功能改善。ST段抬高的患者功能改善更常见(68%对30%,P<0.005),且随访时平均(标准差)改善节段数更多(1.9(2.2)对0.5(1.1),P<0.005)。ST段抬高患者的室壁运动评分指数在基线和随访之间降低(1.54(0.50)对1.48(0.43),P<0.05),而无ST段抬高患者则未降低(1.39(0.60)对1.45(0.47))。在前壁梗死患者中(80%对83%)以及接受血运重建的患者中(分别为78%对83%),ST段抬高预测功能改善的准确性与小剂量多巴酚丁胺超声心动图相似。
在近期Q波心肌梗死患者中,多巴酚丁胺诱发的ST段抬高是心肌存活的一个有价值的标志物,尤其是在超声心动图成像不佳或未进行超声心动图成像时进行该试验。